Nisa Investment Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11K | Buy |
280
+180
| +180% | +$1.36K | ﹤0.01% | 2596 |
|
|
2025
Q1 | $757 | Sell |
100
-45
| -31% | -$341 | ﹤0.01% | 2707 |
|
|
2024
Q4 | $1.77K | Sell |
145
-84
| -37% | -$1.02K | ﹤0.01% | 2528 |
|
|
2024
Q3 | $3.83K | Buy |
229
+64
| +39% | +$1.07K | ﹤0.01% | 2270 |
|
|
2024
Q2 | $2.88K | Buy |
165
+27
| +20% | +$471 | ﹤0.01% | 2335 |
|
|
2024
Q1 | $2.35K | Buy |
138
+21
| +18% | +$358 | ﹤0.01% | 2207 |
|
|
2023
Q4 | $1.19K | Sell |
117
-24
| -17% | -$245 | ﹤0.01% | 2234 |
|
|
2023
Q3 | $1.28K | Buy |
141
+25
| +22% | +$226 | ﹤0.01% | 2366 |
|
|
2023
Q2 | $1.25K | Buy |
116
+107
| +1,189% | +$1.15K | ﹤0.01% | 2406 |
|
|
2023
Q1 | $0 | Sell |
9
-13,891
| -100% | – | ﹤0.01% | 2551 |
|
|
2022
Q4 | $147K | Sell |
13,900
-3,341
| -19% | -$35.3K | ﹤0.01% | 1436 |
|
|
2022
Q3 | $222K | Buy |
17,241
+3,341
| +24% | +$43K | ﹤0.01% | 1246 |
|
|
2022
Q2 | $178K | Buy |
+13,900
| New | +$178K | ﹤0.01% | 1340 |
|